0007名無しのアビガン(公衆) (エムゾネW FFbf-YC9L)
2021/10/20(水) 22:22:23.01ID:0ItiigTIFhttps://www.biorxiv.org/content/10.1101/2021.05.20.444932v1.full
>Phase 2 of the clinical trials is underway.
>Early results show effectiveness of the product in reducing
>sore throat and cough in early stages of SARS-CoV-2 infection.
>In an ongoing phase II of clinical trial, some efficiency have been
>observed from anti-COVID-19 milk using 150ml of hyper immune milk.
イランIsfahan大学の研究
こちらはホルスタインを不活化SARS-CoV-2で免疫化している